Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alice Panchaud

Showing results (41-50 of 137) with videos related to

Pageof 14
Sort By:
Swiss Medical Weekly|August 13, 2024
Exposures to non-therapeutic chemicals before, during and after pregnancy: data from the Swiss Teratogen Information Service (STIS)Piranavie Srikantha, Ursula Winterfeld, Francois Girardin, et al.
Pathogens (Basel, Switzerland)|October 31, 2020
Zika VirusSophie Masmejan, Didier Musso, Manon Vouga, et al.
Nature Reviews. Endocrinology|December 15, 2021
Handle with care - interpretation, synthesis and dissemination of data on paracetamol in pregnancyPer Damkier, Brian Cleary, Corinna Weber-Schoendorfer, et al.
Journal of Clinical Epidemiology|October 12, 2022
The risk of questioning the safety of drugs considered safe in pregnancy at the era of big data: the everlasting case of doxylamineAlice Panchaud, Brian Cleary, Corinna Weber-Schoendorfer, et al.
Pharmacoepidemiology and Drug Safety|October 18, 2024
Drifting Too Far From Shore: Paternal Valproate Statement by the European Medicines Agency (EMA)Per Damkier, Svetlana Shechtman, Orna Diav-Citrin, et al.
Therapie|July 12, 2014
[Pharmacokinetic alterations in pregnancy and use of therapeutic drug monitoring]Alice Panchaud, Etienne Weisskopf, Ursula Winterfeld, et al.
Birth Defects Research|June 9, 2021
Exposure to alirocumab during the first trimester of pregnancy: A case reportYann Vuignier, Floriane Beaud, Christophe Kosinski, et al.
BMJ Open Diabetes Research & Care|January 31, 2023
Major malformations risk following early pregnancy exposure to metformin: a systematic review and meta-analysisNazanin Abolhassani, Ursula Winterfeld, Yusuf C Kaplan, et al.
Pharmacoepidemiology and Drug Safety|July 23, 2019
Identifying pregnancies in insurance claims data: Methods and application to retinoid teratogenic surveillanceSarah C MacDonald, Jacqueline M Cohen, Alice Panchaud, et al.
Clinical and Translational Science|November 27, 2025
Janus Kinase Inhibitors During Pregnancy and Adverse Drug Reactions: A Pharmacovigilance Disproportionality Analysis in VigiBaseNazanin Abolhassani, Roberta Noseda, Kim Dao, et al.
Pageof 14

Showing results (41-50 of 137) with videos related to

Sort By:
Pageof 14
Swiss Medical Weekly|August 13, 2024
Exposures to non-therapeutic chemicals before, during and after pregnancy: data from the Swiss Teratogen Information Service (STIS)Piranavie Srikantha, Ursula Winterfeld, Francois Girardin, et al.
Pathogens (Basel, Switzerland)|October 31, 2020
Zika VirusSophie Masmejan, Didier Musso, Manon Vouga, et al.
Nature Reviews. Endocrinology|December 15, 2021
Handle with care - interpretation, synthesis and dissemination of data on paracetamol in pregnancyPer Damkier, Brian Cleary, Corinna Weber-Schoendorfer, et al.
Journal of Clinical Epidemiology|October 12, 2022
The risk of questioning the safety of drugs considered safe in pregnancy at the era of big data: the everlasting case of doxylamineAlice Panchaud, Brian Cleary, Corinna Weber-Schoendorfer, et al.
Pharmacoepidemiology and Drug Safety|October 18, 2024
Drifting Too Far From Shore: Paternal Valproate Statement by the European Medicines Agency (EMA)Per Damkier, Svetlana Shechtman, Orna Diav-Citrin, et al.
Therapie|July 12, 2014
[Pharmacokinetic alterations in pregnancy and use of therapeutic drug monitoring]Alice Panchaud, Etienne Weisskopf, Ursula Winterfeld, et al.
Birth Defects Research|June 9, 2021
Exposure to alirocumab during the first trimester of pregnancy: A case reportYann Vuignier, Floriane Beaud, Christophe Kosinski, et al.
BMJ Open Diabetes Research & Care|January 31, 2023
Major malformations risk following early pregnancy exposure to metformin: a systematic review and meta-analysisNazanin Abolhassani, Ursula Winterfeld, Yusuf C Kaplan, et al.
Pharmacoepidemiology and Drug Safety|July 23, 2019
Identifying pregnancies in insurance claims data: Methods and application to retinoid teratogenic surveillanceSarah C MacDonald, Jacqueline M Cohen, Alice Panchaud, et al.
Clinical and Translational Science|November 27, 2025
Janus Kinase Inhibitors During Pregnancy and Adverse Drug Reactions: A Pharmacovigilance Disproportionality Analysis in VigiBaseNazanin Abolhassani, Roberta Noseda, Kim Dao, et al.
Pageof 14